forecast reflect updat assumpt incorpor ms
economist team view economi convers actuari
consult privat payor oper outpati surgeri center
consid multipl factor impact mco earn
limit visibl continu updat estim new data point
deferr elect procedur repres meaning benefit
group manag care execut need navig messag earn
call expect exercis high degre conservat forecast
elect procedur come back later year updat forecast
assum procedur come back year-end headwind
commerci membership higher unemploy million
aggreg relat medic cost
estim guidanc provid pre covid outbreak
 in-lin guidanc rang ci
reflect outsiz benefit acceler medicaid
enrol estim
consensu mid point except
key sourc upsid estim percent elect
procedur reschedul set inpati versu outpati
key swing factor estim repres much upsid
captur bull case scenario see exhibit sourc upsid
catalyst unit health report key sentiment
group topic focus underli assumpt cadenc
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
elect procedur return data point around admiss
chang enrol expect higher unemploy
earn see preview note publish today
addit detail see exhibit summari earn estim chang
exhibit earn headwind tailwind associ new
estim assumpt analysi detail differ
assumpt made analysi
four consider earn estim
exhibit summari manag estim vs consensu
morgan stanley estim thomson reuter
prior new ms
exhibit move piec new earn estim
prior new ms
guidanc
guidanc
guidanc
pbm drug retail optum
prior first estim revis
morgan stanley estim compani data
reserv deferr elect procedur deferr elect procedur
meaning benefit bottom line expect manag care execut opt
conservat guid return elect procedur accordingli forecast
assum deferr come back year end repres million
million medic cost ep benefit rel origin guidanc
exhibit analysi exhibit breakdown assumpt
exhibit elect procedur deferr benefit procedur return end
defer orthoped spend
total medic spend
return orthoped spend
total medic spend
net medic tailwind
total medic spend
rate calcul base risk book membership split assumpt commerci medicar medicaid reimburs rate
morgan stanley research rand kaiser famili foundat
cost associ hospit waiv pre
author bill occur discharg post acut treatment cost
think health plan limit visibl ultim medic cost associ
covid analysi cost accru date popul suggest
total medic spend million million april covid-
tracker counti data suggest highest exposur
counti case associ medic cost estim
million follow million
million model assum addit week similar cost base ms
analyst matthew harrison project us case plateau month see
repres total million million medic cost headwind
group exhibit analysi exhibit breakdown assumpt
note analysi includ headwind commerci popul admiss
would drive increment cost potenti higher rate larger payment
reimburs commerci member like paid per diem basi
medicar reimburs drg base consid averag longer length
hospit stay patient suggest payor higher commerci exposur
could see larger headwind compani larger medicar membership
exhibit estim aggreg medic cost member week cost base ms biotech estim
morgan stanley estim kaiser famili foundat journal american medic associ
unemploy us economist predict peak
unemploy rate see exhibit note taper
commerci employ declin like see
substanti increas number uninsur exchang enrol individu
seek medicaid coverag take account macro team forecast
manag care compani market share within commerci medicaid market
incorpor model commerci membership headwind million
live depend compani enrol medicaid exchang tailwind
million live depend compani assum lost commerci
live end medicaid exhibit analysi swing factor whether
unemploy disproportion affect servic industri
necessarili entir repres manag care enrol mix
exhibit enrol headwind commerci tailwind medicaid due higher unemploy
total us medic book
total us medic book
total us medic book
total us medic book
morgan stanley estim compani data
capit deploy share buyback limit visibl futur cost
may risk manag care compani suspend share buyback year
four manag care compani molina
share buyback contempl within guidanc repres earn
could risk see exhibit assum suspend buyback
forecast
compani data estim
sourc upsid estim
percent procedur actual come back expect manag care
execut conserv regard guidanc return elect procedur
see upsid option individu lost job less like reschedul
procedur overal chang consum behavior comfort level return
medic set convers privat payor model assum
model procedur reschedul said consid capac
constraint coverag much procedur may come back
shift return elect procedur inpati outpati
cadenc magnitud return elect procedur remain seen
look color call help triangul discuss suggest
orthoped procedur current push could come back less
expens outpati set rather inpati set could lead
signific cost save overal net benefit could show prior year
develop benefit
exhibit analysi addit per compani save exhibit breakdown
assumpt
exhibit potenti upsid elect procedur come back shift inpati procedur outpati set
defer orthoped spend
total medic spend
return orthoped spend
total medic spend
net medic tailwind
total medic spend
rate calcul base risk book membership split assumpt commerci medicar medicaid reimburs rate
morgan stanley research rand kaiser famili foundat
assumpt analysi
exhibit assumpt elect procedur shift outpati set analysi
annual ortho spend total medic spend
annual ortho spend defer
total procedur come back
inpati procedur move outpati
total medic spend ortho lower end
assum week march
medicar rate base rand studi
total hip knee arthroplasti
medicar rate per kaiser
morgan stanley research rand kaiser famili foundat
exhibit assumpt estim aggreg medic cost analysi
estim number day hospit per patient
hospit surg
co-pay cost day lo
profession fee anesthesiologist administ
percentag covid case senior
hospit rate patient case
icu admiss rate patient case
ventil rate icu patient icu case
drg simpl pneumonia pleurisi cc
drg simpl pneumonia pleurisi mcc
drg respiratori system diagnosi ventil
code ventil assist
manag day one subsequ day
morgan stanley estim kaiser famili foundat journal american medic associ
exhibit unemploy
number unemploy
morgan stanley estim bureau labor statist
execut growth ingeniorx integr medicaid margin upsid
calcul price target appli price-to-earnings multipl base case ep
multipl reect turn discount multipl in-lin
compani year averag discount adjust hif repeal period
fear weigh multipl
largest commerci player
market share second largest
player medicaid exchang
helm new ceo gail
boudreaux anthem focus
improv commerci busi
protabl gain share medicar
advantag market place current
insourc pbm accret earn
posit anthem effect
compet marketplac
view descript risk reward theme
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
ep
bull case multipl reect premium
bull case multipl reect premium
multipl
multipl reect year
averag discount adjust
hif repeal
ep
multipl
multipl multipl in-
line compani year averag
discount adjust hif repeal
period fear weigh
multipl
ep
discount current multipl
discount current multipl
discount trade
last industri price
cycl adjust hif repeal
failur execut pbm transit result
lost prot opportun enrol
view explan region hierarchi
research highest favor quintil
medicar advantag growth market
pbm transit poorli execut result
lower protabl lost member
price pressur govern
commerci busi result margin
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
multipl growth lever wcg rxadvanc execut success
calcul price target appli price-to-earnings multipl base case ep
multipl reect turn premium multipl premium reect
year averag discount adjust repeal hif estimate turn
largest medicaid player
market share
wellcar acquisit expand
market presenc medicar advantag
fastest grow market
stand-alone wellcar outperform
suggest potenti upsid deal accret
base estim break-even
mid-single-digit accret
addit upsid opportun
insourc pbm integr
medic pharmaci benet
repeal would headwind
assign low probabl outcom
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
view descript risk reward theme
ep
premium multipl
premium multipl
in-lin year averag discount
adjust perman repeal
hif
ep
premium multipl
premium multipl
premium reect year averag discount
 adjust repeal hif estimate
ep
multipl
multipl discount in-
line stock trade
last price cycl
texa unit state constitution
view explan region hierarchi
research highest favor quintil
deal wcg drive acceler growth
margin perform high end
rxadvanc grow big market pharmaci
wcg out-performance drive upsid
loss core medicaid contract
exchang protabl less expect
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
vertic integr model w/ opp increas govern commerci share
calcul price target appli price-to-earnings multipl base case ep
multipl reect turn discount current multipl discount
in-lin year average discount adjust hif repeal period
concern weigh multipl longer view like outcom
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
current multipl
current multipl
premium in-lin year averag peak
current multipl
current multipl
appli price-to-earnings multipl base case
ep multipl reect
turn discount current
multipl discount in-lin
year average discount adjust hif repeal
period concern
weigh multipl longer
view like outcom
fourth largest commerci
share exchang share
acquisit esrx creat vertic
integr player better abil
manag medic pharmaci spend
drive signic save member
flexibl balanc sheet deploy
opportun upsel dental vision
ancillari servic help drive acceler
opportun penetr
remain co cross sell area
view descript risk reward theme
current multipl
current multipl
discount in-lin stock
trade trough last
china india
view explan region hierarchi
research highest favor quintil
enterpris synergi ahead
capit deploy grow gov
esrx deal integr fail meet synergi
regulatori uncertainti continu weigh
pbm margin contract competit
commerci enrol growth
materi
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
vertic integr enterpris opp transform healthcar deliveri
pt deriv use sotp analysi assign ev/ebitda multipl
retail normal year average ev/ebitda multipl pharmaci servic
express script multipl month prior acquisit announc
price-to-earnings multipl health benet repres discount current pe in-
line w/ diversi yr average discount adjust hif repeal
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
combin aetna creat fulli
posit premier player
transform us healthcar
envis pivot role
reshap access health care
leverag exist real estat creat
local healthcar hub lead addit
combin aetna provid path
return earn growth
time align aetna
membership cost synergi
acceler pace debt paydown
de-lever underappreci
view descript risk reward theme
multipl repres peak
multipl compani see
share gain strong sell season
valid integr caremark busi
model health benet assum
price-to-earnings multipl base
multipl trade yr average premium
assign ev/ebitda multipl
retail normal year average
ev/ebitda multipl pbm
script multipl month prior
acquisit announc
price-to-earnings multipl repres
discount current pe in-lin
w/ diversi yr average discount
 adjust hif repeal
assum synergi
multipl repres trough
multipl initi /caremark
integr period assum
price-to-earnings multipl trough
aetna multipl period structur
prior assum deal synergi
enterpris modern initi
materi also back present
valu estim cash ow associ
potenti opioid payment
front end store sale
retail rx store sale
month premium medic loss ratio
view explan region hierarchi
research highest favor quintil
integr model drive new health plan
amazon ventur
healthcar front end comp improv
growth exce growth seen
plan buy new model
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
calcul price target appli price-to-earnings multipl base case ep
multipl reect premium multipl in-lin year
averag premium adjust repeal hif estimate period
multipl weigh see like scenario
high earn exposur
medicar advantag
execut organ medicaid
growth earn
medicaid provid addit growth
pipelin copmani
recent medicaid contract win la
ky underscor manag medicaid
strategi play
strong balanc sheet continu
solid cash gener lay foundat
view descript risk reward theme
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
ep
bull case multipl reect premium
bull case multipl reect premium
multipl
multipl in-lin
compani year averag peak premium
ep
base case multipl reect premium
base case multipl reect premium
multipl
multipl reect
year averag premium adjust repeal
hif estimate period
multipl weigh
see like scenario
ep
bear case multipl reect discount
bear case multipl reect discount
current multipl
current multipl
in-lin discount
last price cycl
adjust hif repeal
 strateg ventur leverag footprint
enhanc valu base offer
view explan region hierarchi
research highest favor quintil
abl grow medicaid busi
rfp win tuck-in
compani abl sustain market
margin improv target rang
unabl maintain recent
improv star rate
competit medicar advantag
make growth challeng
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
margin stori near complet top-line growth come focu
calcul price target appli price-to-earnings multipl base case ep
multipl reect discount multipl line
year averag discount adjust hif repeal period time
multipl weigh concern
molina fourth largest player
major revenu
market remaind revenu
deriv exchang
bring exchang top-line back pre-
restructur level addit
win new medicaid rfp key
opportun earn growth
also offer strateg option
manag care peer look fuel medicaid
view descript risk reward theme
bull case ep
bull case multipl reect premium
bull case multipl reect premium
multipl
multipl line
year average premium adjust
hif repeal
base case ep
base case multipl reect discount
base case multipl reect discount
multipl
multipl discount line
year averag discount adjust
hif repeal period time
multipl weigh
bear case ep
bear case multipl reect discount
bear case multipl reect discount
multipl
multipl discount
line trade
last price cycl adj hif
grow exchang enrol sustain
texa unit state constitution
view explan region hierarchi
research highest favor quintil
enrol grow back level
protabl margin
peer look grow medicaid
recent margin follow cost cut fail
sustain compani pursu top-line growth
margin
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
return histor growth optum epicent earn potenti
calcul price target appli price-to-earnings multipl base case ep
multipl reect turn premium multipl in-lin
year averag premium histor trade adjust repeal hif
period fear weigh multipl believ
outcom like
number one
medicar advantag player
market share number two medicar
pdp player market share
number two commerci player
unit model enhanc via vertic
integr optumrx pbm platform
one three largest pbm
countri
larg lead breadth servic
offer consider exposur
govern busi well
posit potenti chang
strong balanc sheet continu
solid cash gener give exibl
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
apr gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
view descript risk reward theme
ep
bull case multipl reect premium
bull case multipl reect premium
multipl
multipl premium in-lin
year averag peak adjust
discount repeal hif
ep
premium multipl
premium multipl
premium in-lin year averag
premium histor trade
adjust repeal hif
period fear
weigh multipl believ
outcom like
ep
multipl
multipl discount in-
line stock trade
last price cycl adj
optum margin esp optumrx
view explan region hierarchi
research highest favor quintil
growth market
optum integr lead industri lead
medicaid margin improv target
slower growth core growth area
medicar advantag commerci medicaid
focu servic
optum growth slow competitor becom
reluct work unitedhealth
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
